Comparing Out-of-Pocket Costs and Health-Related Quality of Life Between Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes

Comparing Out-of-Pocket Costs and Health-Related Quality of Life Between Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes

Sisi Hu,1 Preeti Pushpalata Zanwar,1– 3 Tara Jenkins,1 Rajkumar J Sevak,1 Bhaskara R Jasti1 1Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA, USA; 2Thomas Jefferson University, Philadelphia, PA, USA; 3Texas A&M University, College Station & Kingsville, Kingsville,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hu S, Zanwar PP, Jenkins T, Sevak RJ, Jasti BR
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Drug, Healthcare and Patient Safety
Subjects:
sglt2 inhibitor
glp-1 receptor agonist
medical expenditure panel survey
health care expenditure
health-related quality of life
Online Access:https://www.dovepress.com/comparing-out-of-pocket-costs-and-health-related-quality-of-life-betwe-peer-reviewed-fulltext-article-DHPS
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/comparing-out-of-pocket-costs-and-health-related-quality-of-life-betwe-peer-reviewed-fulltext-article-DHPS

Similar Items